ENANTA PHARMACEUTICALS INC
Public company- Headquarters
- WATERTOWN, Massachusetts
- Ticker
- ENTA
- CIK
- 0001177648
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CEOJay R. Luly, Ph.D. | Oct 28, 2026 | Departed |
| COOTara L. Kieffer, Ph.D. | Oct 28, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- VERTEX PHARMACEUTICALS INC / MA
new member of the board of directors appointed: Daniel Brennan
- Ernexa Therapeutics Inc.
member of the Board appointed: Robert J. Spiegel, M.D.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Executive departure
CEO departs: Jay R. Luly, Ph.D.
Jay R. Luly, Ph.D., President and Chief Executive Officer of ENANTA PHARMACEUTICALS INC, retires the role, effective February 1, 2027. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 28, 2026Role: President and Chief Executive Officer
- Executive appointment
COO appointed: Tara L. Kieffer, Ph.D.
Tara L. Kieffer, Ph.D. was named Chief Operating Officer of ENANTA PHARMACEUTICALS INC, effective October 28, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 28, 2026Role: Chief Operating Officer
Last verified Nov 8, 2026